ResearcherFudan University Shanghai Cancer CenterNo recent work listed

Lina Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-7184-7407; OpenAlex author ID A5101558576. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

A clinical study of serum human epididymis protein 4 (HE4) in the diagnosis of pancreatic cancer. Last author DOI 10.4103/ijc.ijc_752_19 ↗
Do Patients Diagnosed with Metastatic Pancreatic Cancer Benefit from Primary Tumor Surgery? A Propensity-Adjusted, Population-Based Surveillance, Epidemiology … First author DOI 10.12659/msm.917106 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weiqi Liu · 1 shared paper, 2022 · strength 0.19
- Paper A clinical study of serum human epididymis protein 4 (HE4) in the diagnosis of pancreatic cancer. DOI 10.4103/ijc.ijc_752_19 ↗
Zhen Chen · 1 shared paper, 2019 · strength 0.14
- Paper Do Patients Diagnosed with Metastatic Pancreatic Cancer Benefit from Primary Tumor Surgery? A Propensity-Adjusted, Popu… DOI 10.12659/msm.917106 ↗
Lianyu Chen · 1 shared paper, 2019 · strength 0.14
- Paper Do Patients Diagnosed with Metastatic Pancreatic Cancer Benefit from Primary Tumor Surgery? A Propensity-Adjusted, Popu… DOI 10.12659/msm.917106 ↗
Lai Wang · 1 shared paper, 2019 · strength 0.14
- Paper Do Patients Diagnosed with Metastatic Pancreatic Cancer Benefit from Primary Tumor Surgery? A Propensity-Adjusted, Popu… DOI 10.12659/msm.917106 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.